Hydrus® Microstent New Enrollment Post-Approval Study (NCT04553523)
The Hydrus® Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm, Clinical Trial
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24 months post-operation. Qualified subjects will undergo uncomplicated cataract surgery with placement of a monofocal intraocular lens (IOL), followed by implantation of the Hydrus Microstent.
Who can join: Review the eligibility criteria below.
Location: Coastal Vision — Irvine, California
Age range: 45 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (22 Sites)
- Coastal Vision — Irvine, California
- Sacramento Eye Consultants — Sacramento, California
- Eye Center of Northern Colorado — Loveland, Colorado
- Jones Eye Center PC — Sioux City, Iowa
- Stiles Eyecare Excellence Cataracts and Glaucoma — Overland Park, Kansas
- Visionary Eye Doctors — Rockville, Maryland
- Fraser Eye Care Center — Fraser, Michigan
- Twin Cities Eye Consultants — Coon Rapids, Minnesota
- Midwest Vision Research Foundation — Chesterfield, Missouri
- Moyes Eye Center — Kansas City, Missouri
- Center for Sight — Las Vegas, Nevada
- Carolina Eye Associates PA — Southern Pines, North Carolina
- Cleveland Eye Clinic — Brecksville, Ohio
- Cincinnati Eye Institute — Cincinnati, Ohio
- Cincinnati Eye / Apex Eye — Mason, Ohio
- Scott & Christie and Associates, PC — Cranberry Township, Pennsylvania
- Texan Eye / Keystone Research — Austin, Texas
- Glaucoma Associates Of Texas — Dallas, Texas
- El Paso Eye Surgeons — El Paso, Texas
- Texas Eye Research Center — Hurst, Texas
- The Eye Institute of Utah — Salt Lake City, Utah
- Eye Centers Of Racine And Kenosha — Kenosha, Wisconsin
📞 Contact the Study Coordinator
Phone: (888) 451-3937
Email: alcon.medinfo@alcon.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Primary Open Angle Glaucoma
- A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX) — Panama City,
- Advanced Glaucoma Progression Study — Los Angeles, California
- Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study — Palo Alto, California
- Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery) — Las Vegas, Nevada
- A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma — Glendale, Arizona
Explore by condition: All Primary Open Angle Glaucoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.